Pfizer COVID-19 vaccine shows promise in adolescents

Pfizer says the COVID-19 vaccine which is being administered to adults is very effective in adolescent patients as well. According to a news release, the vaccine was shown to demonstrate 100 percent efficacy and robust antibody responses in a Phase 3 trial in adolescents from 12 to 15 years old. These results exceed those which were recorded when the vaccine was administered to patients from 16 to 25 years old.
Read more...

;